J F Kelly|D F Hake - JoVE Visualize

Showing results (91-100 of 94) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 94 results.

Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neuronsJ F Kelly, K Furukawa, S W Barger, et al.

Optics Letters|December 15, 2007

Kilohertz linewidth from frequency-stabilized mid-infrared quantum cascade lasersR M Williams, J F Kelly, J S Hartman, et al.

Journal of Clinical Microbiology|August 30, 2001

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal resultsB Van Der Pol, D H Martin, J Schachter, et al.

Seminars in Radiation Oncology|March 28, 2002

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary resultsR Komaki, J S Lee, B Kaplan, et al.

Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 94 results.

Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neuronsJ F Kelly, K Furukawa, S W Barger, et al.

Optics Letters|December 15, 2007

Kilohertz linewidth from frequency-stabilized mid-infrared quantum cascade lasersR M Williams, J F Kelly, J S Hartman, et al.

Journal of Clinical Microbiology|August 30, 2001

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal resultsB Van Der Pol, D H Martin, J Schachter, et al.

Seminars in Radiation Oncology|March 28, 2002

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary resultsR Komaki, J S Lee, B Kaplan, et al.

Pageof 10